Nimit Rajesh Ghatalia Increases Stake in Aarey Drugs & Pharmaceuticals to 5.18%
Aarey Drugs & Pharmaceuticals Ltd 路 Acquisition/ Disposal of Shares 路 05 Oct 2026, 4:22 pm
Nimit Rajesh Ghatalia Increases Stake in Aarey Drugs & Pharmaceuticals to 5.18% Nimit Rajesh Ghatalia acquired 150,000 equity shares (0.47% voting capital) of Aarey Drugs & Pharmaceuticals Ltd on 30th Sep'26 through warrant conversion. The non-promoter acquirer previously held 1,500,000 shares (4.88%) alongside 150,000 convertible warrants (0.49%). Post-allotment, total equity shareholding stands at 1,650,000 shares, representing 5.18% of total voting capital and 4.94% on a fully diluted basis. Following the conversion, the company's total voting capital increased from 30,724,303 to 31,874,303 equity shares of Rs. 10 each, with diluted capital at 33,354,303 shares.
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- Statement of deviation and variation for the quarter ended September 30, 2026 路 15 Nov 2026
- As per attachment 路 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... 路 15 Nov 2026
- Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve This is to intimate .... 路 14 Nov 2026
- Revised outcome 路 07 Oct 2026
